Prelude Therapeutics Inc ($PRLD)
Filing Information
| Accession Number | 0001193125-26-265965 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 10, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
76,000
Total Value
$0.00
P&L
+inf% (+$300,200.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Non-Qualified Stock Option (right to buy) | Derivative | Jun 9, 2026 | Grant/Award | 38,000 | $0.00 | $0.00 | 38,000 | Indirect | See Footnotes | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | Jun 9, 2026 | Grant/Award | 38,000 | $0.00 | $0.00 | 38,000 | Indirect | See Footnotes | View Details |